Vol 72 No 4 (2019): The Indian Practitioner - April 2019 | The Indian Practitioner

Skip to main content Skip to main navigation menu Skip to site footer

Published: 2019-04-24

Editorial

Addressing Multidrug-Resistant Tuberculosis

Dr. Ravindran Chetambath

8-10
- Requires Subscription PDF

Original Article

Study of Antimicrobial Susceptibility of Staphylococcus Aureus to Pristinamycin by Disc Diffusion Method and MIC by E Test

Dr. Swati Kale , Dr. Ashwini Patil

22-26
- Requires Subscription PDF

Opinion

Garcia de Orta – The First European Qualified Physician in India

Dr Ashoka Jahnavi Prasad

42-43
- Requires Subscription PDF
Opinion- Alternate Treatment for Diabetes

Dr. Rohit Madhav Sane

44-45
- Requires Subscription PDF

Review article

Clinical Review of Roxithromycin in respiratory tract infections

Dr Abhijeet Shirsat, Dr. Devendra Khandke

27-33
- Requires Subscription PDF
Fosfomycin, Single-dose Oral Antibiotic for Uncomplicated UTI – A Review

Dr. Manish Maladkar, Vaibhav Revandkar, Srividya shankar

34-41
- Requires Subscription PDF

Alternative Medicine

Alternative Medicine

The Indian Practitioner

55-57
- Requires Subscription PDF

Medi Matters

Medi Matters

The Indian Practitioner

12-21
- Requires Subscription PDF

Drug Profile

SofteronGoldTM SofteronGoldTM is used for the treatment of iron deficiency and iron deficiency anemia (IDA), the most prevalent form of nutritional disorder worldwide.

The Indian Practitioner

46-47
- Requires Subscription PDF
Recently Approved Drugs for Cystic Fibrosis

Dr. Prabhakar Singh

48-49
- Requires Subscription PDF

Nutraceuticals

Nutraceuticals

The Indian Practitioner

50-54
- Requires Subscription PDF

Medi News

Medi News

The Indian Practitioner

58-38
- Requires Subscription PDF

Events

Events

The Indian Practitioner

69-70
- Requires Subscription PDF